Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial. (Q36614629)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2006

Language	Label	Description	Also known as
English	Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial.	scientific article published on May 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

Alessandro Morabito

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Massimo Di Maio

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Nicola Normanno

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

C Pacilio

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

F Nuzzo

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A Gravina

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

V Labonia

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G Landi

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

E Rossi

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

E De Maio

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

G D'Aiuto

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

C Gallo

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

F Perrone

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

A de Matteis

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

NCI-Naples Breast Cancer Group

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

94

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1233-1236

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

30 September 2017

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

30 September 2017

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

30 September 2017

Use of predictive probabilities in phase II and phase III clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

28 June 2018

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8081.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

28 June 2018

Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

20 September 2018

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361414

20 September 2018

Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Prognostic factors in the response of a first line chemotherapy in advanced breast cancer]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of adjuvant chemotherapy with or without anthracyclines on the activity and efficacy of first-line cyclophosphamide, epidoxorubicin, and fluorouracil in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16622454

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6603096

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16622454%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36614629&oldid=2215768995"